Clinical Efficacy of Brown Seaweeds Ascophyllum nodosum and Fucus vesiculosus in the Prevention or Delay Progression of the Metabolic Syndrome: A Review of Clinical Trials
Open Access
- 30 January 2021
- Vol. 26 (3), 714
- https://doi.org/10.3390/molecules26030714
Abstract
Metabolic syndrome (MetS) is a global public health problem affecting nearly 25.9% of the world population characterised by a cluster of disorders dominated by abdominal obesity, high blood pressure, high fasting plasma glucose, hypertriacylglycerolaemia and low HDL-cholesterol. In recent years, marine organisms, especially seaweeds, have been highlighted as potential natural sources of bioactive compounds and useful metabolites, with many biological and physiological activities to be used in functional foods or in human nutraceuticals for the management of MetS and related disorders. Of the three groups of seaweeds, brown seaweeds are known to contain more bioactive components than either red and green seaweeds. Among the different brown seaweed species, Ascophyllum nodosum and Fucus vesiculosus have the highest antioxidant values and highest total phenolic content. However, the evidence base relies mainly on cell line and small animal models, with few studies to date involving humans. This review intends to provide an overview of the potential of brown seaweed extracts Ascophyllum nodosum and Fucus vesiculosus for the management and prevention of MetS and related conditions, based on the available evidence obtained from clinical trials.Funding Information
- BioAtlantis Ltd. (Russel PhD Studentship Agreement (Ref. LSC 2018_66).)
This publication has 106 references indexed in Scilit:
- Human Gut Microbiota Changes Reveal the Progression of Glucose IntolerancePLOS ONE, 2013
- Dipeptidylpeptidase-IV, a key enzyme for the degradation of incretins and neuropeptides: activity and expression in the liver of lean and obese ratsEuropean Journal of Histochemistry, 2012
- Immunostimulatory Effect of Laminarin on RAW 264.7 Mouse MacrophagesMolecules, 2012
- Antiviral Activities of Sulfated Polysaccharides Isolated from Sphaerococcus coronopifolius (Rhodophytha, Gigartinales) and Boergeseniella thuyoides (Rhodophyta, Ceramiales)Marine Drugs, 2011
- Antioxidant capacity of sulfated polysaccharides from seaweeds. A kinetic approachFood Hydrocolloids, 2011
- Unraveling the Directional Link between Adiposity and Inflammation: A Bidirectional Mendelian Randomization ApproachJournal of Clinical Endocrinology & Metabolism, 2010
- Anticancer Drugs from Marine Flora: An OverviewJournal of Oncology, 2010
- Total phenolic compounds, radical scavenging and metal chelation of extracts from Icelandic seaweedsFood Chemistry, 2009
- Inflammation and metabolic disordersNature, 2006
- Dipeptidyl-Peptidase IV from Bench to Bedside: An Update on Structural Properties, Functions, and Clinical Aspects of the Enzyme DPP IVCritical Reviews in Clinical Laboratory Sciences, 2003